Course of Portal Hypertension and Applicability of Noninvasive Tests After Recompensation in Alcohol-related Cirrhosis
Benedikt Hofer(Austrian Academy of Sciences), M Trauner(Medical University of Vienna), Paul Thöne(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), L Balcar(Medical University of Vienna), Daniel König(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Thomas Reiberger(ERN GUARD-Heart), M Hintersteininger(Medical University of Vienna), Albert Friedrich Stättermayer(Medical University of Vienna), Christian Sebesta(Donauspital), Mattias Mandorfer(Medical University of Vienna), Georg Kramer(Medical University of Vienna), Nina Dominik(Medical University of Vienna)
Cited by 3
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119